Rebecca Taub
Company: Madrigal
Job title: Chief Executive Officer
Seminars:
10:30 am Navigating the Path to the First MASH Therapeutic Approval & Progressing Beyond to Advance Clinical Development Strategies to Expand the Horizon of Approved Drugs 10:30 am
Delving into the strategic clinical development and trial design methodologies that led to the unprecedented first therapeutic approval in MASH, setting a crucial benchmark for future candidates Reviewing the comprehensive clinical data and real-world evidence to demonstrate the significant efficacy and safety profiles that underpin the treatment’s success and inform optimal patient management Exploring how…Read more
day: Conf day 2
9:15 am Spotlighting Madrigal’s MASH Breakthrough to Explore the Treatment Success & Benchmark for the Next Therapeutic Era 9:15 am
Informing on Madrigal’s breakthrough drug to further understand how it succeeded in revolutionizing the MASH treatment landscape, leading to a new standard of care for patients Reviewing compelling evidence from robust clinical data and real-world evidence to demonstrate the treatment’s significant effectiveness to inform on treatment decisions and improve patient outcomes Examining ongoing research and…Read more
day: Conf Day 1